Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo — Rhonda Bentley–Lewis (2015) | RDL Network
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
Marc A. Pfeffer, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber, Francesca Lawson, Ping Lin, Xiaodan Wei, Eldrin F. Lewis, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif
Marc A. Pfeffer, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber, Francesca Lawson, Lin Ping, Xiaodan Wei, Eldrin F. Lewis, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif
Mukul Sharma, Robert G. Hart, Eric E. Smith, Jackie Bosch, Fei Yuan, Amparo Casanova, John W. Eikelboom, Stuart J. Connolly, G.C. Wong, Rafael Díaz, Patricio López‐Jaramillo, Georg Ertl, Stefan Störk, Gilles R. Dagenais, Eva Lonn, Lars Rydén, Andrew Tonkin, George Varigos, Deepak L. Bhatt, Kelley R. Branch, Jeffrey L. Probstfield, Jae‐Hyung Kim,
Patrícia O. Guimarães, Marcelo Franken, Caio A.M. Tavares, Fábio Serra Silveira, Murillo de Oliveira Antunes, Ricardo Reinaldo Bergo, Rodrigo M Joaquim, Jessica C S Hirai, Pedro Beraldo de Andrade, Fábio Grunspun Pitta, José Mariani, Bruno Ramos Nascimento, João Eduardo Tinoco de Paula, Marcos S. Silveira, Tiberio A O Costa, Frederico Toledo Campo Dall’Orto, Renato G Serpa, Fernanda B A Sampaio, Louis N Ohe, Fernanda Mangione, Remo H.M. Furtado,
Marc A. Pfeffer, John J.V. McMurray, Alain Leizorovicz, Aldo Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Marc Henis, Eric Neuhart, Paul Gallo, Susan Edwards, Mary Ann Sellers, Eric J. Velazquez, Robert M. Califf
Discussion(0)
No comments yet. Be the first to comment.